While the precise mechanisms remain unclear, it is believed that IFN-γ stimulates the JAK/STAT signaling pathway in melanoma cells, leading to upregulation of immune checkpoint molecules like programmed death-ligand 1 (PD-L1), which helps melanoma cells evade immune attack [12]. The gene discussed is IFNG; the disease is melanoma.